Glioma, Tumor volumes, Contouring, GTV + 2 cm margin = CTV, Trim bone, trim along the ventricles, and optic apparatus, brain stem

chemoradiation, nasopharynx, radical RT, concurrent chemo RT, nasopharyngeal carcinoma, CCRT, NACT, gemcitabine, cisplatin, capecitabine, NPC, IMRT

nodal metastases, nasopharynx, N3, SCM, digastric anterior limit and lateral, parotid gland, platysma,

sino-nasal malignancies, paranasal sinuses, PNS, nasal cavity, rarity, air/soft tissues, mucosa/bone, RT contouring, RT planning, SNUC, sinonasal undifferentiated carcinoma, maxilla, ethmoid sinus, perineural spread, salivary gland tumors, lymphatic and distant spread, risk factors, papillomaviru...

carcinoma, middle cranial fossa, oral pharynx, oral cavity, nasal cavity, nasopharynx, PPF, foramen rotundum, foramen lacerum, infra temporal fossa, pharyngeal canal, vidian canal, PNI, eustachian tube opening, torus tubarius, fossa of Rosenmüller, MRI, sagittal nasopharynx, sphenoid sinus, soft ...

DARS optimized radiotherapy, head and neck cancer, organ and function preservation, HNSCC therapy intensification, tumor control, acute and late toxicities, treatment induced dysphagia, dysphagia and aspiration related structures, pharyngeal constrictors, glottic and supra glottic larynx, anxiety...

Locally advanced head and neck squamous cell carcinoma, LAHNSCC, LA-HNSCC, LA HNSCC, PD-1, PDL-1, PD1, PDL1, Nivolumab, Pembrolizumab, Radiation enhances MHC class I surface expression,calreticulin expression, and release of HMGB1, GORTEC 2015-01 (PembroRad) Randomized Trial in Cisplatin-Unfit Pa...